Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Fish and Richardson
Healthtrust
Harvard Business School
QuintilesIMS
Chinese Patent Office
Citi
Moodys
Boehringer Ingelheim
Federal Trade Commission

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017116

« Back to Dashboard
NDA 017116 describes METHADOSE, which is a drug marketed by Mallinckrodt Inc and Mallinckrodt and is included in three NDAs. It is available from three suppliers. Additional details are available on the METHADOSE profile page.

The generic ingredient in METHADOSE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.

Summary for NDA: 017116

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 017116

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 017116

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHADOSE
methadone hydrochloride
CONCENTRATE;ORAL 017116 NDA Mallinckrodt, Inc. 0406-0527 0406-0527-10 1000 mL in 1 BOTTLE, PLASTIC (0406-0527-10)
METHADOSE
methadone hydrochloride
CONCENTRATE;ORAL 017116 NDA Mallinckrodt, Inc. 0406-0527 0406-0527-15 15000 mL in 1 BOTTLE, PLASTIC (0406-0527-15)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CONCENTRATE;ORALStrength10MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Novartis
Cerilliant
Federal Trade Commission
Argus Health
Chubb
Queensland Health
Covington
Dow
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot